FDA Approves Bepreve for the Treatment of Itching Associated With Allergic Conjunctivitis
Links shared publicly online about this topic.
- 1,933total visits
FDA Approves Bepreve for the Treatment of Itching Associated With Allergic Conjunctivitis
View full resource at eyedocnews.com
Tags: Allergies, Eye Allergy, Dermatology, Eye, Conjunctivitis, Drug, FDA
Most Recently Shared on June 30, 2009 at 2:49 am By:
Discuss: Bepreveâ„¢ Eye Drops from ISTA Obtain Approval of FDA Dermatologic and Ophthalmic Drugs Advisory .. http://tinyurl.com/n6a5aw
ISTA's Bepreve™ Receives FDA Approval for Allergic Conjunctivitis
eyedocnews.com — “ISTA Pharmaceuticals, Inc. has announced that the FDA has approved Bepreve™1.5% as a twice a day prescription eye drop treatment for ocular itching associated with allergic conjunctivitis.” View full resource at eyedocnews.com
Most Recently Shared on September 17, 2009 at 9:36 am By:
Dr. Ari Weitzner Physician, Doctor, and Ophthalmologist
Discuss: ISTA Pharmaceuticals’ Bepreve™ Receives FDA Approval For Ocular Itching Associated With Allergi.. http://bit.ly/2mdVSi
Ista Pharmaceuticals' Bepreve Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies
drugs.com — “Bepreve (bepotastine besilate ophthalmic solution) is used to treat ocular itching associated with allergic conjunctivitis. Includes Bepreve side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on September 14, 2009 at 10:21 pm By:
FDA Approves Bepreve for the Treatment of Ocular Itching Due to Allergies - http://bit.ly/nfPSD
Bepreve approved for ocular itch - MPR
empr.com — “The FDA has approved Bepreve (bepotastine besilate ophthalmic solution, from ISTA Pharmaceuticals), a histamine H1 receptor antagonist, for the treatment of itching associated with signs and symptoms of allergic conjunctivitis.” View full resource at empr.com
Most Recently Shared on September 9, 2009 at 4:38 pm By:
MPR News: Bepreve approved for ocular itch: The FDA has approved Bepreve (bepotastine besilate ophthalm.. http://bit.ly/106rzR
Advertisement
